eeking to toughen the Sunshine Act, Sen. Claire McCaskill (D-Mo.) plans to introduce a bill that would require drug makers to report payments that are made to nonprofit organizations and patient advocacy groups, according to several sources familiar with the effort.

The move comes eight years after the Sunshine Act was created in response to concerns that industry payments were unduly influencing medical research and practice, an issue that arose after a Senate Finance Committee probe. The law was subsequently folded into the Affordable Care Act and a federal database was launched in 2014 to which companies must report payments to physicians.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.